Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: Member Spotlight

HPP Weekly Update - July 16 2018

Monday, July 16, 2018   (0 Comments)
Posted by: TCAA Staff
Share |

 

 

Week of July 16, 2018

Hospital Preparedness Program

HPP Weekly Update

 

Upcoming Important Dates

· July 18: HPP-PHEP Recipient Conference Call

This Week’s Updates

This Week’s Updates

Here’s what you need to know:

HPP Spotlight

· HPP Spotlight: NYC Health Department Releases Video to Highlight HPP-funded Pediatric Exercise

Grants Management

· HPP-PHEP Recipient Conference Call Scheduled for July 18

ASPR TRACIE

· Recording Now Available: Health Care Challenges after Radiological Incidents

· New Resource Available: Blood and Blood Products Topic Collection

· ASPR TRACIE Technical Assistance Spotlights: Pediatric Resources

Around ASPR

· ASPR Blog: New Smallpox Antiviral Increases National Health Security

· On Twitter

 

HPP Spotlight: NYC Health Department Releases Video to Highlight HPP-funded Pediatric Exercise

The NYC Health Department released a video to spotlight the Pediatric Surge Exercise they conducted on May 25, 2018. The exercise included participation from all 28 NYC hospitals with pediatric capabilities, as well as the NYC Fire Department, NYC Emergency Management, and other agencies.The exercise demonstrated the ability of NYC’s health care system to double pediatric intensive care unit capacity citywide. Click here to watch the video and to learn more about how HPP supports the development of pediatric capabilities.


Grants Management

HPP-PHEP Recipient Conference Call Scheduled for July 18

The July HPP-PHEP recipient conference call will be held from 3:00 – 4:00 PM ET on Wednesday, July 18, 2018. Participant information is provided below.

· Bridge Line: (888) 832-5936

· Participant Code: 3358383

ASPR TRACIE

Recording Now Available: Health Care Challenges after Radiological Incidents

On July 11, 2018, ASPR TRACIE held a webinar discussing the impact of radiological incidents on health and health care, as well as planning strategies related to different incidents. The speakers shared guidance and lessons learned from recent exercises and research in assessing, triaging, treating, and following up on casualties of radiological and nuclear emergencies. The presentation and recording from this webinar are now available. The link to the recording is on the title page of the presentation; enter you email address prior to viewing.

 

 

New Resource Available: Blood and Blood Products Topic Collection

The ASPR TRACIE Blood and Blood Products Topic Collection highlights lessons learned from recent mass casualty incidents; relevant plans, tools, and templates; resources on supply chain modeling; and additional resources. Please see the accompanying Blood and Blood Products FAQ document.

 

 

ASPR TRACIE Technical Assistance Spotlights: Pediatric Resources

On average, ASPR TRACIE receives over 100 requests for technical assistance (TA) per month. Some of their redacted responses are summarized here and can be found in the Information Exchange to benefit stakeholders. ASPR TRACIE will periodically highlight TAs that may be of particular interest to stakeholders in these weekly reports,

This ASPR TRACIE TA response includes resources related to existing policy guides and templates for pediatric surge and caring for pediatric patients with access and functional needs.

Around ASPR

ASPR Blog: New Smallpox Antiviral Increases National Health Security

In the 20th century alone, smallpox deaths worldwide numbered in the hundreds of millions. Roughly one-third of people infected with the disease died, while survivors were often left with permanent scars or blindness. After an aggressive global vaccination program in the mid-1970s, the World Health Organization declared smallpox eradicated.

But smallpox remains a health security threat in the 21st century. Fears that undeclared stocks of the smallpox virus might exist and that they could be used as weapons of bioterrorism spurred the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) to fund the advanced research and development of antiviral drugs against smallpox. Today, the Food and Drug Administration (FDA) approved the use of TPOXX® (tecovirimat), produced by SIGA Technologies, as a treatment for smallpox.

Read More

 

 

On Twitter

Follow ASPR @PHEgov!

· Taking #influenza diagnostics out of the lab and into the home could transform the speed and delivery of treatment. BARDA is supporting the development of two influenza tests that will be available over the counter. Click here to learn more.

· Millions of people rely on durable medical equipment (DME) to live independently & manage chronic conditions. Find out how healthcare systems can prepare to meet the needs of patients who rely on DME when disaster strikes. Click here to learn more.

Note: ASPR provides the above sources of information for the convenience of the HPP community and is not responsible for the availability or content of the information or tools provided, nor does ASPR endorse, warrant or guarantee the products, services or information described or offered. It is the responsibility of the user to determine the usefulness and applicability of the information provided.


Association Management Software Powered by YourMembership  ::  Legal